$0.602
-0.026 (-4.28%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による CTXR の予測・予想
Alphio's CTXR stock price prediction model matches the current Citius Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.60 (+0.09%). The 1-week path is $0.59 (-1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Citius Pharmaceuticals Inc 株は買うべき？
Citius Pharmaceuticals Inc is a good buy right now due to its recent revenue growth of $7.1 million in Q3 2026, reflecting a significant market acceptance of its product LYMPHIR. Additionally, the gross margin for Q1 2026 was an impressive 79.99%, indicating strong profitability potential. However, the main risk is the net loss of $28.11 million reported in Q2 2026, which raises concerns about financial sustainability.
CTXR の株価は Friday に $0.60 で引け、その前に下落 -4.28%
Citius Pharmaceuticals Inc (CTXR) last closed at $0.6021, losing -4.28%. These facts feed the 1-day and 1-week CTXR price prediction above.
アナリストのコンセンサス
Citius Pharmaceuticals Inc（CTXR）：買い 1、中立 0、売り 0。見通し：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Citius Pharmaceuticals Inc（CTXR）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが CTXR に最も近い銘柄を、類似度順に表示します。
CTXR の季節性分析
Historically the probability of a positive August return for CTXR is 9.52%. April offers the highest probability of a positive month at 28.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。